NEBULA IMMUNOTEC AS
Operating
Utvikling av immunologiske produkter til Akvakultur industrien.
Forskning og utvikling av immunologiske produkter til Akvakultur
industrien.
Organization
- Chairman of the board
- CX
Cheng Xu1982
- Years since formation
- 1 year
- since Jul 14, 2025
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Financials
- Annual total result 2025
- -6,502
- NOK
- Total equity 2025
- 23,499
- NOK
Last update: Jun 10, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
CX 1982 | Chairman | - |
KF 1967 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Last update: Jun 8, 2026
Ownership
No available data
Financials
in NOK
Summary
| Year | 2025 |
|---|---|
Total operating income | 0 |
Annual Total Result | -6,502 |
Total assets | 23,499 |
Total liabilities | 0 |
Total equity | 23,499 |
P&L
| Year | 2025 |
|---|---|
Total operating income | 0 |
Total operating costs | 6,502 |
Operating result | -6,502 |
Financial income/costs | 0 |
Profit before tax | -6,502 |
Total tax & extraordinary income/cost | 0 |
Annual Total Result | -6,502 |
Balance overview
| Year | 2025 |
|---|---|
Total fixed assets | 0 |
Total current assets | 23,499 |
Total assets | 23,499 |
Short term debt | 0 |
Long term debt | 0 |
Total liabilities | 0 |
Contributed capital | 30,000 |
Retained earnings | -6,502 |
Total equity | 23,499 |
Total equity and liabilities | 23,499 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises